Researchers have made important strides in understanding and treating diffuse midline gliomas, which were long seen as a death sentence for the children and adolescents they affect.
New studies are shedding light on how the tests could eventually transform treatment.
ABC News’ Dr. Tara Narula explains a discovery that could help doctors predict and prevent the world’s deadliest cancer.
| Channel | t.me/News_Wire2 |
| Source | https://abcnews.com/video/133611514/ |
| Keywords | lung-cancercancerpreventiondr-tara-narulaabc-newsmedicinehealthcareearly-detectionmedical-discoveryoncologyhealthdoctors |
Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the odds of a tumor developing.
Families with rare gene mutations that cause Alzheimer's in middle age are giving scientists a unique window on the disease, and a quick way to test potential treatments.
“The greatest barrier to saving lives from pancreatic cancer has been our inability to see the disease when it is still curable,” Dr. Ajit Goenka said.
It's a very treatable form of cancer if caught early, yet younger adults rarely get screened. Patient advocates want more people to talk to their doctors about risk factors and number 2.
Until recently, a patient could not receive an Alzheimer’s diagnosis without an expensive scan or invasive procedure. Last year, the FDA cleared two blood-based biomarker tests—or BBB—that require only a routine blood sample for use in diagnosing Alzheimer’s disease. This is an important step forward in Alzheimer’s care, but it won’t mean much to patients unless they are given affordable access to these tests. Right now, federal law prohibits the Medicare program from covering BBB tests without very specific constraints being met, such as a review from the little-known U.S. Preventative Services Task Force or an act of Congress. More than 7 million Americans have Alzheimer’s, and a recent report found that over 90% of…